HBM Holdings wholly-owned subsidiary Nona Biosciences has signed an agreement for the expansion of its antibody discovery collaboration with BeiGene.
15 Sep 2023
14 Sep 2023
Lonza company Synaffix has signed a licensing agreement with ABL Bio for the development of bispecific antibody drug conjugates (ADCs).
13 Sep 2023
Salipro Biotech and Sumitomo Pharma have entered into a research partnership for advancing a drug discovery programme.
06 Sep 2023
RaQualia Pharma’s sublicensee United Italian Trading (UITC) has launched the tegoprazan drug for the treatment of gastroesophageal reflux disease (GERD), in Singapore.
04 Sep 2023
Innovac Therapeutics has raised $18m in Series Pre-A financing for funding the development of its lead programmes and manufacturing capabilities.
29 Aug 2023
Allucent has received a contract from the Biomedical Advanced Research and Development Authority (BARDA) to expedite clinical research and development of next-generation booster vaccines for Covid-19.
08 Aug 2023
Daiichi Sankyo has announced its decision to shut down its Japanese research and development (R&D) subsidiary to further strengthen its capabilities.
02 Aug 2023
Precision-medicine company Solu Therapeutics has raised $31m in seed financing to develop the Cytotoxicity Targeting Chimera (CyTaC) platform and drug candidates.
01 Aug 2023
Viatris and Kindeva Drug Delivery have launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat certain asthma and chronic obstructive pulmonary disease (COPD) patients.
25 Jul 2023
The China National Medical Products Administration (NMPA) has accepted and granted priority review to Overland ADCT BioPharma’s biologics license application (BLA) for ZYNLONTA (loncastuximab tesirine-lpyl).